title: In a Rare Head-to-Head Matchup, New Psoriasis Drug Seems a Winner.
abstract: Taltz is indicated for the treatment of adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is delivered as a subcutaneous injection. The agent comes as either a pre-filled syringe or an autoinjector and can be self-injected after proper training and with physician supervision.
authors.forename: Thomas
authors.initials: T
authors.lastname: Morrow
mesh_terms: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C549079:ixekizumab